CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea
· Delayed Price · Currency is KRW 1,725.00
-75.00 (-4.17%)
Mar 9, 2026, 3:30 PM KST
CMG Pharmaceutical Revenue
CMG Pharmaceutical had revenue of 30.40B KRW in the quarter ending September 30, 2025, with 23.01% growth. This brings the company's revenue in the last twelve months to 100.41B, up 6.41% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.
Revenue (ttm)
100.41B
Revenue Growth
+6.41%
P/S Ratio
2.54
Revenue / Employee
450.29M
Employees
223
Market Cap
255.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
| Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
| Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
| Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
| Dec 31, 2018 | 49.86B | 8.33B | 20.05% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boditech Med | 151.75B |
| JW Holdings | 935.51B |
| Hyundai Pharmaceutical | 108.14B |
| BNC Korea | 98.11B |
| Korea United Pharm | 161.44B |
| Suheung | 704.47B |
| Ilyang Pharmaceutical Co.,Ltd | 276.09B |
| Chong Kun Dang Holdings | 950.10B |